Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Acceleron Pharma

Explore full profile

Biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics

Cambridge, United StatesFounded 2004Biotech & Life Sciences
Valuation $12B Market cap · 2026
Revenue $135M Latest reported FY

At a glance

Status
Listed
Founded
2004
Headquarters
Cambridge, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later11 investors entered at this stage

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Acceleron Pharma employees who went on to found companies, sorted by Dealroom signal score.

AN2 TherapeuticsEst. 2019
JZJoe ZakrzewskiUnited States
Signal score76
KallyopeEst. 2015
TMTom ManiatisUnited States
Signal score65
OvaScienceEst. 2011
Christoph WestphalUnited States
Signal score61
Oorja BioEst. 2023
Sujay KangoUnited States
Signal score55
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown
Web traffic by country
50 monthly visits
across markets
🇺🇸 United States0%
Top 1 markets shown

Patents

Estimated portfolio value
$328M

101 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Acceleron Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acceleron Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles